Abstract:Background: Umbilical cord blood (UCB) is a clinically relevant alternative source of hematopoietic stem/progenitor cells (HSPC). To overcome the low cell number per UCB unit, ex vivo expansion of UCB HSPC in co-culture with mesenchymal stromal cells (MSC) has been established. Bone marrow (BM)-derived MSC have been the standard choice, but the use of MSC from alternative sources, less invasive and discardable, could ease clinical translation of an expanded CD34+ cell product. Here, we compare the capacity of BM-, umbilical cord matrix (UCM)-, and adipose tissue (AT)-derived MSC, expanded with/without xenogeneic components, to expand/maintain UCB CD34+-enriched cells ex vivo. Methods: UCB CD34+-enriched cells were isolated from cryopreserved mononuclear cells and cultured for 7 days over an established feeder layer (FL) of BM-, UCM-, or AT-derived MSC, previously expanded using fetal bovine serum (FBS) or fibrinogen-depleted human platelet lysate (HPL) supplemented medium. UCB cells were cultured in serum-free medium supplemented with SCF/TPO/FLT3-L/bFGF. Fold increase in total nucleated cells (TNC) as well as immunophenotype and clonogenic potential (cobblestone area-forming cells and colony-forming unit assays) of the expanded hematopoietic cells were assessed. Results: MSC from all sources effectively supported UCB HSPC expansion/maintenance ex vivo, with expansion factors (in TNC) superior to 50x, 70x, and 80x in UCM-, BM-, and AT-derived MSC co-cultures, respectively. Specifically, AT-derived MSC co-culture resulted in expanded cells with similar phenotypic profile compared to BM-derived MSC, but resulting in higher total cell numbers. Importantly, a subpopulation of more primitive cells (CD34+CD90+) was maintained in all co-cultures. In addition, the presence of a MSC FL was essential to maintain and expand a subpopulation of progenitor T cells (CD34+CD7+). The use of HPL to expand MSC prior to co-culture establishment did not influence the expansion potential of UCB cells. Conclusions: AT represents a promising alternative to BM as a source of MSC for co-culture protocols to expand/maintain HSPC ex vivo. On the other hand, UCM-derived MSC demonstrated inferior hematopoietic supportive capacity compared to MSC from adult tissues. Despite HPL being considered an alternative to FBS for clinical-scale manufacturing of MSC, further studies are needed to determine its impact on the hematopoietic supportive capacity of these cells.

Mesenchymal Stem Cell-Derived Microvesicles Support Ex Vivo Expansion of Cord Blood-Derived CD34+ Cells

Ex Vivo Expansion and Transplantation of Hematopoietic Stem/progenitor Cells Supported by Mesenchymal Stem Cells from Human Umbilical Cord Blood.

[Biological Characteristics of Mesenchymal Stem Cells in Human Umbilical Cord Blood and Their Supporting Capacities in Ex Vivo Expansion of CD34+ Hematopoietic Stem Cells].

Effects of bone marrow-derived mesenchymal stem cell layer on expansion and differentiation of hematopoietic stem cells from cord blood

Mesenchymal Stem/Progenitor Cells in Human Umbilical Cord Blood As Support for Ex Vivo Expansion of Cd34(+) Hematopoietic Stem Cells and for Chondrogenic Differentiation

Marrow Mesenchymal Stem Cells Transduced with Tpo/Fl Genes As Support for Ex Vivo Expansion of Hematopoietic Stem/Progenitor Cells

Ex Vivo Expansions and Transplantations of Mouse Bone Marrow-Derived Hematopoietic Stem/progenitor Cells

Support of hMSCs transduced with TPO/FL genes to expansion of umbilical cord CD34 + cells in indirect co-culture

Cord Blood Plasma and Placental Mesenchymal Stem Cells-Derived Exosomes Increase Ex Vivo Expansion of Human Cord Blood Hematopoietic Stem Cells While Maintaining Their Stemness

The Effect of Mesenchymal Stem Cell-Derived Microvesicles on Erythroid Differentiation of Umbilical Cord Blood-Derived CD34+ Cells

Adherent Cell Layer from Human Umbilical Cord Blood and Its Support to Ex Vivo Expansion of Hematopoietic Stem/progenitor Cells

Ex vivo expansion of human umbilical cord blood hematopoietic stem/progenitor cells with support of microencapsulated rabbit mesenchymal stem cells in a rotating bioreactor

In Vitro Expansion of Hematopoietic Stem/progenitor Cells from Human Umbilical Cord Blood.

Ex Vivo Expansion of Cord Blood Hematopoietic Stem/Progenitor with Support of Microencapsulated Mesenchymal Stem Cells in Rotating Wall Vessel

Wharton’s Jelly Mesenchymal Stem Cell-Based or Umbilical Vein Endothelial Cell-Based Serum-Free Coculture with Cytokines Supports the Ex Vivo Expansion/maintenance of Cord Blood Hematopoietic Stem/progenitor Cells

MiRNAs and piRNAs from bone marrow mesenchymal stem cell extracellular vesicles induce cell survival and inhibit cell differentiation of cord blood hematopoietic stem cells: a new insight in transplantation

Influence of the mesenchymal stromal cell source on the hematopoietic supportive capacity of umbilical cord blood-derived CD34+-enriched cells

Effect of VCAM-1 Modified Human Umbilical Cord Blood Stromal Cells on Expansion of Hematopoietic Stem/progenitor Cells

Simultaneous Expansion and Harvest of Hematopoietic Stem Cells and Mesenchymal Stem Cells Derived from Umbilical Cord Blood

[Study on the Ex Vivo Expansion Characteristics of Umbilical Cord Blood CD34+ Cells and Mononuclear Cells].

Effects of encapsulated rabbit mesenchymal stem cells on ex vivo expansion of human umbilical cord blood hematopoietic stem/progenitor cells